Ross Morton

Ross founded Nodenza and leads the Fund in identifying new investment opportunities, engaging with Limited Partners and day to day operations. He sits on the Investment Committee.

Ross was COO of Akaza Bioscience, sold to Aquarious Bio in 2022. Prior, he was on the management team of Izana Bioscience, which sold to one of the Roivant companies in 2020.

Previously, Ross was a management consultant in the Advisory practice at Kinapse, a Syneos company supporting Big Pharma R&D projects.